Bailey & Company: credited tech M&A deals
Deals in the ProCloser Tech & SaaS M&A Deal Index where Bailey & Company was named as an advisor in a public source. Back to the advisor league.
Bailey & Company is an M&A advisory firm publicly credited on 2 deals in the ProCloser Tech M&A Deal Index (2 sell-side, 0 buy-side), announced between Mar 31, 2026 and Sep 15, 2026.
Sectors: Healthtech (2). 0 of 2 credited deals disclosed a value.
Last updated Oct 16, 2026.
Bailey & Company sits at #31 of 161 (tied with 30 other firms) in the advisor league by credited deals, while the median firm in the league holds 1 credited deal. Ties share the better rank. The targets in Bailey & Company's record, oldest first, are Vital Data Technology and Andros. The first credit in Bailey & Company's record is Vital Data Technology on Mar 31, 2026 and the latest is Andros on Sep 15, 2026, a span of 168 days. That works out to one credited deal every 168 days on average, and the longest quiet stretch was 168 days between Vital Data Technology and Andros. The sections below walk through each of those deals, the buyers and co-advisors involved, and how Bailey & Company compares inside every sector it is credited in, all computed from the rows of the index.
Credited deals
Where Bailey & Company advised the buyer, the credit appears as "Buy-side" beneath the sell-side advisor cell. Values only where publicly disclosed; every row links to its source.
| Date | Target | Acquirer | Buyer type | Sector | Geo (target → acquirer) | Value | Sell-side advisor | Source |
|---|---|---|---|---|---|---|---|---|
| Androscredentialing verification for health plans/providers | Medallion | Strategic | Healthtech | US → US | Undisclosed | Bailey & Company | Press release | |
| Vital Data Technologyhealthcare payer workflow and analytics platform | MedReview | Strategic | Healthtech | US → US | Undisclosed | Bailey & CompanyBuy-side: Synergy Advisors | Press release |
Credits for Bailey & Company appear only where Bailey & Company was named in a public announcement.
Bailey & Company, deal by deal, newest first
One paragraph for each of the 2 deals credited to Bailey & Company, written from the fields of the row and the linked source. A clause appears only when the index holds that field.
Medallion acquires Andros (sell-side, Sep 15, 2026)
Bailey & Company is credited as sell-side advisor on this deal, which means Bailey & Company advised Andros on the sale to Medallion. Medallion acquired Andros, an NCQA-certified credentials verification organization for health plans and providers, for undisclosed terms. The announcement Bailey & Company was credited on is dated Sep 15, 2026, and the index files Andros under Healthtech in the sub-sector of credentialing verification for health plans/providers. In Bailey & Company's record the tags attached to Andros are credentialing, provider enrollment, healthcare compliance and cvo. The index classes Medallion as a strategic buyer. Andros is based in the United States and Medallion in the United States, so the index treats it as a domestic deal. No price was disclosed for Andros, so no figure is entered for it. The source names no advisor other than Bailey & Company on the Andros deal. In the date order of Bailey & Company's own record this is credit 2 of 2, announced 168 days after the Vital Data Technology credit, and credit 2 of 2 in Healthtech. The announcement behind the Andros credit: Medallion Acquires Andros to Expand AI-Native Credentialing Across Health Plans and Provider Organizations, PR Newswire (press release). The index rates this row high confidence.
MedReview acquires Vital Data Technology (sell-side, Mar 31, 2026)
Bailey & Company is credited as sell-side advisor on this deal, which means Bailey & Company advised Vital Data Technology on the sale to MedReview. MedReview acquired Vital Data Technology, a healthcare payer workflow and predictive analytics platform provider, for undisclosed terms. The announcement Bailey & Company was credited on is dated Mar 31, 2026, and the index files Vital Data Technology under Healthtech in the sub-sector of healthcare payer workflow and analytics platform. In Bailey & Company's record the tags attached to Vital Data Technology are payer analytics, population health, risk adjustment, care management and healthcare ai. The index classes MedReview as a strategic buyer. Vital Data Technology is based in the United States and MedReview in the United States, so the index treats it as a domestic deal. No price was disclosed for Vital Data Technology, and the index never estimates one. Synergy Advisors advised the other side of the table from Bailey & Company. In the date order of Bailey & Company's own record this is credit 1 of 2, the earliest credit, and credit 1 of 2 in Healthtech. The announcement behind the Vital Data Technology credit: MedReview Announces Acquisition of Vital Data Technology (press release). The index rates this row high confidence.
Bailey & Company in charts
Bailey & Company: deals by quarter
Data table
| Quarter | Bailey & Company deals |
|---|---|
| Q1 2026 | 1 |
| Q2 2026 | 0 |
| Q3 2026 | 1 |
Who Bailey & Company worked with
Co-advisors
1 of the 2 deals credited to Bailey & Company names at least one other advisor, and the other 1 names Bailey & Company alone. 1 other firm appears next to Bailey & Company: 0 on the same side and 1 across the table. Synergy Advisors is the most frequent counterpart, sharing 1 deal with Bailey & Company.
| Firm | With Bailey & Company on one side | Across the table from Bailey & Company | Shared deals |
|---|---|---|---|
| Synergy Advisors | 0 | 1 | Vital Data Technology |
Acquirers
The 2 deals credited to Bailey & Company involve 2 distinct acquirers. By buyer type the mix behind Bailey & Company's deals is strategic (2).
| Acquirer | Buyer type | Deals with Bailey & Company | Largest disclosed | Targets |
|---|---|---|---|---|
| Medallion | Strategic | 1 | Undisclosed | Andros |
| MedReview | Strategic | 1 | Undisclosed | Vital Data Technology |
Sector context for Bailey & Company
How the credits of Bailey & Company compare with the whole index in each sector where Bailey & Company is credited.
Healthtech: Bailey & Company against the sector
Bailey & Company is credited on 2 of the 16 advised Healthtech deals, a 12% share, which puts Bailey & Company #1 of 19 (tied with 3 other firms) among Healthtech advisors. Behind that share, the index tracks 129 Healthtech deals in all, and 16 of them (12%) name an advisor.
Bailey & Company's Healthtech credits are Andros (Medallion, Sep 15, 2026, Undisclosed); Vital Data Technology (MedReview, Mar 31, 2026, Undisclosed).
For the full Healthtech picture beyond Bailey & Company, see Healthtech sector record (JSON).
What Bailey & Company's targets look like
The businesses Bailey & Company advised on are described in the index as credentialing verification for health plans/providers and healthcare payer workflow and analytics platform.
Across Bailey & Company's 2 credited rows the tags that recur most are care management, credentialing, cvo, healthcare ai, healthcare compliance, payer analytics, population health and provider enrollment.
Target countries recorded for Bailey & Company's deals: the United States (2), known for 2 of 2 rows.
Buyer countries recorded for Bailey & Company's deals: the United States (2), known for 2 of 2 rows.
0 deals in Bailey & Company's record are flagged cross-border.
Advisors related to Bailey & Company
Firms credited in the most of the same sectors as Bailey & Company, nearest in credited-deal count first. Names link to a profile only where the firm has one.
- Synergy Advisors: 1 sector in common with Bailey & Company (Healthtech), 2 credited deals against 2 for Bailey & Company
- Scotiabank: 1 sector in common with Bailey & Company (Healthtech), 1 credited deal against 2 for Bailey & Company
- ATB Cormark: 1 sector in common with Bailey & Company (Healthtech), 1 credited deal against 2 for Bailey & Company
- TripleTree: 1 sector in common with Bailey & Company (Healthtech), 3 credited deals against 2 for Bailey & Company
- CIBC Capital Markets: 1 sector in common with Bailey & Company (Healthtech), 1 credited deal against 2 for Bailey & Company
Machine-readable record for Bailey & Company
The same credits as structured data, with an evidence label on every row: JSON record and Markdown record. Both are licensed CC BY 4.0 and rebuilt daily with this page.
Frequently asked questions about Bailey & Company
How many deals is Bailey & Company credited on in this index?
Bailey & Company is credited on 2 deals: 2 sell-side and 0 buy-side, announced between Mar 31, 2026 and Sep 15, 2026. The targets are Vital Data Technology and Andros. 0 of the 2 disclosed a price. That count covers only deals verified by the ProCloser index, each with a public source naming Bailey & Company, and is not the firm's full track record.
Which sectors does Bailey & Company advise in?
Bailey & Company is credited in Healthtech (2). Healthtech is the largest at 2 of 2 credited deals (100%). The index tracks 11 sectors in total, so Bailey & Company appears in 1 of them.
What is the largest deal Bailey & Company was credited on?
No deal credited to Bailey & Company disclosed a price, so there is no largest disclosed value to report for Bailey & Company. Undisclosed prices stay undisclosed in the index and are never estimated.
Is Bailey & Company mostly a sell-side or a buy-side advisor?
Bailey & Company is sell-side on 2 of 2 credited deals (100%) and buy-side on 0 (0%). Across all 332 credits in the index, 59% are sell-side, so Bailey & Company is more sell-side heavy than the league as a whole.
Which acquirers has Bailey & Company worked with?
Bailey & Company has worked on deals involving 2 acquirers. The most frequent in Bailey & Company's record: Medallion (1) and MedReview (1). Buyer types: strategic (2).
How does Bailey & Company rank against the typical advisor in the league table?
Bailey & Company is #31 of 161 (tied with 30 other firms) by credited deals, against a league median of 1 credited deal. Bailey & Company has no disclosed value to rank. Rankings reflect public credits in this index only and undercount firms that rarely announce their deals.
Where does the data on Bailey & Company come from?
Each of the 2 credits for Bailey & Company links to a public source, split by type as press release (2). A firm is credited only when its name appears in that source text; we do not add credits for Bailey & Company from memory or from third-party databases.
Which firms advised alongside Bailey & Company?
1 other firm appear on the same deals as Bailey & Company, led by Synergy Advisors (1). 1 of 2 deals credited to Bailey & Company name another advisor.
How do I get an introduction to a firm like Bailey & Company?
If you are selling a Healthtech company or another software business, get matched and ProCloser will introduce you to a vetted M&A advisory firm that fits your sector and deal size, free to sellers. Bailey & Company is one of 161 firms credited in the index and ranks #31 of 161 (tied with 30 other firms) by credited deals.
Get matched with the right advisor for your deal.
The advisors credited in this index work deals like yours every quarter. Tell us about your company and we will match you with a vetted M&A advisory firm in your sector and size range, including success-fee-only options. Free to sellers.